Microrna-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting SOX9

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Yang, Bo ^a   Guo, Hongfeng ^a   Zhang, Yulan ^a,b   Chen, Lei ^c   Ying, Dajun ^a   Dong, Shiwu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

^c SOUTHWEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; MESSENGER RNA; MICRORNA; MICRORNA 145; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; LUCIFERASE; MIRN145 MICRORNA, MOUSE; SOX9 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA3;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; MARKER GENE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN RNA BINDING; ANIMAL; CELL LINE; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; REPORTER GENE;

MURINAE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CHONDROGENESIS; DOWN-REGULATION; GENES, REPORTER; LUCIFERASES; MESENCHYMAL STEM CELLS; MICE; MICRORNAS; SOX9 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA3;

EID: 79960569238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021679     Document Type: Article

References (53)

1. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, et al. (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
3. Csaki C, Schneider PRA, Shakibaei M, (2008) Mesenchymal stem cells as a potential pool for cartilage tissue engineering. Annals of Anatomy-Anatomischer Anzeiger 190: 395-412.
4. Pittenger MF, (2008) Mesenchymal stem cells from adult bone marrow. Methods Mol Biol 449: 27-44.
5. Fan HB, Zhang CL, Li J, Bi L, Qin L, et al. (2008) Gelatin microspheres containing TGF-beta 3 enhance the chondrogenesis of mesenchymal stem cells in modified pellet culture. Biomacromolecules 9: 927-934.
6. Mehlhorn AT, Schmal H, Kaiser S, Lepski G, Finkenzeller G, et al. (2006) Mesenchymal stem cells maintain TGF-beta-mediated chondrogenic phenotype in alginate bead culture. Tissue Eng 12: 1393-1403.
7. Furumatsu T, Ozaki T, Asahara H, (2009) Smad3 activates the Sox9-dependent transcription on chromatin. Int J Biochem Cell Biol 41: 1198-1204.
8. Bartel DP, (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Lee Y, Ahn C, Han JJ, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
10. Yi R, Qin Y, Macara IG, Cullen BR, (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011-3016.
11. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U, (2004) Nuclear export of microRNA precursors. Science 303: 95-98.
12. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, et al. (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
13. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
14. Cheng AM, Byrom MW, Shelton J, Ford LP, (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Research 33: 1290-1297.
15. Chen CZ, Li L, Lodish HF, Bartel DP, (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
16. Forstemann K, Tomari Y, Du T, Vagin VV, Denli AM, et al. (2005) Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein. PLoS Biol 3: e236.
17. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, et al. (2005) Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 19: 489-501.
18. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, et al. (2005) MicroRNA expression in zebrafish embryonic development. Science 309: 310-311.
19. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, et al. (2006) The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. Febs Letters 580: 4214-4217.
20. Kobayashi T, Lu J, Cobb BS, Rodda SJ, McMahon AP, et al. (2008) Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proceedings of the National Academy of Sciences of the United States of America 105: 1949-1954.
21. Pais H, Nicolas FE, Soond SM, Swingler TE, Clark IM, et al. (2010) Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level. Rna-a Publication of the Rna Society 16: 489-494.
22. Lin EA, Kong L, Bai XH, Luan Y, Liu CJ, (2009) miR-199a*, a Bone Morphogenic Protein 2-responsive MicroRNA, Regulates Chondrogenesis via Direct Targeting to Smad1. Journal of Biological Chemistry 284: 11326-11335.
23. Yang B, Guo H, Zhang Y, Dong S, Ying D, (2011) The microRNA expression profiles of mouse mesenchymal stem cell during chondrogenic differentiation. Bmb Reports 44: 28-33.
24. Chen X, Guo X, Zhang H, Xiang Y, Chen J, et al. (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28: 1385-1392.
25. Sachdeva M, Mo YY, (2010) MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1. Cancer Research 70: 378-387.
26. Michael MZ, O'Connor SM, Pellekaan NGV, Young GP, James RJ, (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Molecular Cancer Research 1: 882-891.
27. Xu N, Papagiannakopoulos T, Pan GJ, Thomson JA, Kosik KS, (2009) MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells. Cell 137: 647-658.
28. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
29. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, et al. (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. Journal of Clinical Investigation 119: 2634-2647.
30. Xin M, Small EM, Sutherland LB, Qi XX, McAnally J, et al. (2009) MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes & Development 23: 2166-2178.
31. Kawakami Y, Tsuda M, Takahashi S, Taniguchi N, Esteban CR, et al. (2005) Transcriptional coactivator PGC-1 alpha regulates chondrogenesis via association with Sox9. Proceedings of the National Academy of Sciences of the United States of America 102: 2414-2419.
32. Zeng L, Kempf H, Murtaugh LC, Sato ME, Lassar AB, (2002) Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev 16: 1990-2005.
33. Ikeda T, Kamekura S, Mabuchi A, Kou I, Seki S, et al. (2004) The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis and Rheumatism 50: 3561-3573.
34. Akiyama H, Stadler HS, Martin JF, Ishii TM, Beachy PA, et al. (2007) Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. Matrix Biology 26: 224-233.
35. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nature Genetics 37: 495-500.
36. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
37. Ko MH, Kim S, Hwang DW, Ko HY, Kim YH, et al. (2008) Bioimaging of the unbalanced expression of microRNA9 and microRNA9*during the neuronal differentiation of P19 cells. Febs Journal 275: 2605-2616.
38. Kong YW, Cannell IG, de Moor CH, Hill K, Garside PG, et al. (2008) The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proceedings of the National Academy of Sciences of the United States of America 105: 8866-8871.
39. Flynt AS, Li N, Thatcher EJ, Solnica-Krezel L, Patton JG, (2007) Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nature Genetics 39: 259-263.
40. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ, (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proceedings of the National Academy of Sciences of the United States of America 105: 1516-1521.
41. Doench JG, Petersen CP, Sharp PA, (2003) siRNAs can function as miRNAs. Genes & Development 17: 438-442.
42. Carrington JC, Ambros V, (2003) Role of microRNAs in plant and animal development. Science 301: 336-338.
43. Zeng Y, Yi R, Cullen BR, (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proceedings of the National Academy of Sciences of the United States of America 100: 9779-9784.
44. Wang Y, Sul HS, (2009) Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab 9: 287-302.
45. Gangaraju VK, Lin HF, (2009) MicroRNAs: key regulators of stem cells. Nature Reviews Molecular Cell Biology 10: 116-125.
46. Lakshmipathy U, Hart RP, (2008) Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26: 356-363.
47. Karlsen TA, Shahdadfar A, Brinchmann JE, (2010) Human primary articular chondrocytes, chondroblasts-like cells and dedifferentiated chondrocytes: differences in gene, microRNA and protein expression and phenotype. Tissue Eng Part C Methods.
48. Ella L, Quintavalle M, Zhang J, Contu R, Cossu L, et al. (2009) The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death and Differentiation 16: 1590-1598.
49. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B, (1999) Sox9 is required for cartilage formation. Nat Genet 22: 85-89.
50. Liu CJ, Zhang Y, Xu K, Parsons D, Alfonso D, et al. (2007) Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators. Frontiers in Bioscience 12: 3899-3910.
51. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H, (2005) Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. Journal of Biological Chemistry 280: 8343-8350.
52. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74.
53. Soleimani M, Nadri S, (2009) A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4: 102-106.